Position in GOVX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$371,569
+$119,036 QoQ
Shares Held
269,253
+1160.8% QoQ
Ownership
3.65%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GOVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,521,563,900 across 51 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
|
1,736,000 | $66,888,080 |
All Filings in GOVX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $371,569 | 269,253 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $252,533 | 533,897 | Shares | Sole | 2025-11-17 | |
| 2025-03-31 | $702,658 | 662,885 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $254,800 | 80,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $356,000 | 178,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $587,172 | 1,626,516 | Shares | Sole | 2024-02-13 | |
| 2022-06-30 | $1,127,504 | 1,358,439 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $500,422 | 435,150 | Shares | Sole | 2022-05-16 | |
| 2020-09-30 | $160,980 | 50,464 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||